Abstract:Substitution of the C-1 atom in the 2-deoxystreptamine moiety of gentamicin C2, a broad-spectrum aminoglycoside antibiotic, by an axial hydroxymethyl group has been reported to confer protection against most clinically important bacterial enzymes inactivating aminoglycosides, while simultaneously reducing the nephrotoxic potential of this drug. We report here on a similar modification of kanamycin B. Microbiological evaluation, however, revealed no useful protection, as established by the almost complete lack of activity of 1-C-(hydroxymethyl)kanamycin B against an array of organisms producing defined types of aminoglycoside-inactivating enzymes and against which 1-C-(hydroxymethyl)gentamicin C2 and amikacin (1-N-[(S)-2-hydroxy-4-aminobutyryl]kanamycin A) are active. Moreover, toxicological evaluation, based on the in vitro measurement of the drug inhibitory potential toward lysosomal phospholipases, a predictive test of the intrinsic nephrotoxic potential of aminoglycosides, showed not decreased but rather increased toxicity. Comparative conformational analysis of the interactions of the drug with a phosphatidylinositol monolayer explained the lack of protective effect, since no significant change of the mode of insertion of the derivative in this monolayer was detected compared to that of kanamycin B. Combination of a 1-C-(hydroxymethyl) substituent with a 6"-chloro, 6"-acetamido substituent resulted in a partial improvement of the toxicological behavior with no loss of activity for the 6"-chloro and the 6"-azido derivatives, but not to the extent of obtaining better derivatives than kanamycin B itself. We, therefore, suggest that the advantages of an axial hydroxymethyl substituent at C-1 are probably restricted to the gentamicin family and do not extend to kanamycins. It might be concluded that the structural differences between gentamicins and kanamycins play an important, still undescribed role both in their effective recognition by aminoglycoside-inactivating enzymes, which are responsible for most of the clinically important cases of resistance to aminoglycosides, and also in the interactions with phospholipids, which in turn cause nephrotoxicity.

Selective Deprotection of the Cbz Amine Protecting Group for the Facile Synthesis of Kanamycin A Dimers Linked at N-3″ Position

Accelerated Effect on Mitsunobu Reaction Via Bis-N-tert-butoxycarbonylation Protection of 2-Amino-6-chloropurine and Its Application in a Novel Synthesis of Penciclovir

Synthesis of kanamycin A derivatives by regioselective masking drug resistant enzymes targeting hydroxyl groups

Regioselective Modification of Amino Groups in Aminoglycosides Based on Cyclic Carbamate Formation

Design, synthesis, and antibacterial activities of conformationally constrained kanamycin A derivatives.

Kanamycin‐Cu(II) Complex Catalyzed Ullmann Amine Synthesis at Room Temperature: A Tool for Mechanistic Insights into Methylene Blue Degradation

An Efficient and Facile Synthesis of N-Cbz-β-aminoalkanesulfonamides

Selective protection of ribostamycin by cyclic carbamates

Developing Deprotectase Biocatalysts for Synthesis.

Combined KOH/BEt<sub>3</sub> Catalyst for Selective Deaminative Hydroboration of Aromatic Carboxamides for Construction of Luminophores

Mechanism and selectivity of N-triflylphosphoramide catalyzed (3(+) + 2) cycloaddition between hydrazones and alkenes.

THE STUDY ON DIALKYLPHOSPHORYL GROUP AS THE AMINO PROTECTION GROUP

Convenient synthesis of urea-linked hydroxyl-alkylamine derivatives of aminoglycosides

Amphos-Mediated Conversion of Alkyl Azides to Diazo Compounds and One-Pot Azide-Site Selective Transient Protection, Click Conjugation, and Deprotective Transformation

New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation

Deprotective Functionalization: A Direct Conversion of Nms‐Amides to Carboxamides Using Carboxylic Acids

A concise effective deprotection of spiro 3-cyclic thiaza ketal of steroidal 1,4-dien-3-one

Practical Synthesis from Streptomycin and Regioselective Partial Deprotections of (-)-(1 R ,2 S ,3 R ,4 R ,5 S ,6 S )-1,3-Di(deamino)-1,3-diazido-2,5,6-tri- O -benzylstreptamine

Design, Synthesis, and Bioassay of 2 '-Modified Kanamycin A

A study on the structure, mechanism, and biochemistry of kanamycin B dioxygenase (KanJ)—an enzyme with a broad range of substrates

Chemical Synthesis of Proteins Using an o -Nitrobenzyl Group as a Robust Temporary Protective Group for N-Terminal Cysteine Protection